Electrospun tri-layer nanodepots for sustained release of acyclovir
Source abstract
Abstract
Abstract New strategies based on complex nanostructures for developing advanced functional materials providing sustained release of loaded active ingredients are highly desired in various scientific fields. In the present study, a new strategy was proposed to prepare a trilayer nanodepot, in which a drug reservoir was built into a core–shell nanofiber. A modified triaxial electrospinning was implemented to prepare the trilayer depots F2 using cellulose acetate and acyclovir as polymer matrix and active ingredient, respectively. For comparison, a core–shell nanofiber F1 with a blank polymer coating on a drug-loaded nanocomposite was created using a modified coaxial electrospinning. Although nanofibers F1 and nanodepots F2 had the same drug and polymeric components and similar linear morphologies, they exhibited considerably differences in providing the drug-sustained release profiles. Trilayer depots F2 could manipulate a better drug-sustained release profile with a small tailing-off time period. This finding is attributed to the change in drug diffusion mechanism. A constant diffusion distance from a saturated drug reservoir ensured a controllable drug-sustained release rate and a quick late drug exhaustion from trilayer nanodepots. The proposed strategy serves as a new method for developing process–structure–performance relationships at nanoscale for functional applications.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Conducting polymers and applications · Advanced Sensor and Energy Harvesting Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (61)
Show source-provided references
1. Electrospun formulations of bevacizumab for sustained release in the eye10.1016/j.actbio.2017.10.015 ↗
2. Preparation of curcumin loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells10.1039/c1nr10484e ↗
3. Preparation of adenosine-loaded electrospun nanofibers and their application in bone regeneration10.1166/jbn.2019.2761 ↗
4. Antioxidant, antibacterial and antifungal electrospun nanofibers for food packaging applications10.1016/j.foodres.2019.108927 ↗
5. Polyelectrolyte complex from cationized casein and sodium alginate for fragrance controlled release10.1016/j.colsurfb.2019.03.017 ↗
6. A nanofiber-based drug depot with high drug loading for sustained release10.1016/j.ijpharm.2020.119397 ↗
7. Development of a carbon-based slow release fertilizer treated by bio-oil coating and study on its feedback effect on farmland application10.1016/j.jclepro.2019.118085 ↗
8. The development and bio-applications of multifluid electrospinning
9. Challenges and innovations of drug delivery in older age10.1016/j.addr.2018.09.003 ↗
10. Fabrication and biocompatibility of core-shell structured magnetic fibrous scaffold10.1166/jbn.2019.2701 ↗
11. Discrete drug distributions within electrospun tri-layer core-shell nanofibers for accurate dual-stage release10.1016/j.carbpol.2020.116477 ↗
12. Comparative study of electrospun crystal-based and composite-based drug nano depots10.1016/j.msec.2020.110988 ↗
13. Microfluidic preparation of polymer-lipid Janus microparticles with staged drug release property10.1016/j.jcis.2019.06.069 ↗
14. Preparing composite nanoparticles for immediate drug release by modifying electrohydrodynamic interfaces during electrospraying10.1016/j.powtec.2017.12.066 ↗
15. Ethylcellulose-based drug nano depots fabricated using a modified triaxial electrospinning10.1016/j.ijbiomac.2020.02.239 ↗
16. Electrosprayed hydrophilic nanocomposites coated with shellac for colon-specific delayed drug delivery10.1016/j.matdes.2018.02.016 ↗
17. Electrospinning process and applications of electrospun fibers
18. Preparation and characterization of poly(pluronic-co-l-lactide) nanofibers for tissue engineering10.1016/j.ijbiomac.2013.03.061 ↗
19. Sheath-separate-core nanocomposites fabricated using a trifluid electrospinning10.1016/j.matdes.2020.108782 ↗
20. Preparation and therapeutic application of docetaxel-loaded poly(d,l-lactide) nanofibers in preventing breast cancer recurrence10.3109/10717544.2015.1048490 ↗
21. Growth of uniform g-C3N4 shells on 1D TiO2 nanofibers via vapor deposition approach with enhanced visible light photocatalytic activity10.1016/j.jallcom.2020.154001 ↗
22. Flexible self-supporting bifunctional [TiO2/C]//[Bi2WO6/C] carbon-based Janus nanofiber heterojunction photocatalysts for efficient hydrogen evolution and degradation of organic pollutant10.1016/j.jallcom.2020.154673 ↗
23. Differentiation of photon generation depended on electrospun configuration in Eu3+/Tb3+ doped polyacrylonitrile nanofibers10.1016/j.jallcom.2019.02.012 ↗
24. Electrospun Janus nanofibers loaded with drug and inorganic nanoparticles for effective antibacterial wound dressing10.1016/j.msec.2020.110805 ↗
25. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend10.1016/S0168-3659(02)00041-X ↗
26. Extended release of dexamethasone from oleogel based rods10.1016/j.jcis.2019.07.082 ↗
27. Electrospun amorphous solid dispersions of poorly water-soluble drugs: a review10.1016/j.jconrel.2018.08.016 ↗
28. Formulation of novel chitosan guargum based hydrogels for sustained drug release of paracetamol10.1016/j.ijbiomac.2017.12.008 ↗
29. The relationships between the working fluids, process characteristics and products from the modified coaxial electrospinning of zein10.3390/polym11081287 ↗
30. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release10.1021/acs.chemrev.5b00346 ↗
31. Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications10.1016/j.biomaterials.2004.10.018 ↗
32. Electrospinning of cyclodextrin functional nanofibers for drug delivery applications
33. Electrosprayed sperical ethylcellulose nanoparticles for an improved sustained-release profile of anticancer drug10.1007/s10570-017-1498-0 ↗
34. A platform direct compression formulation for low dose sustained-release tablets enabled by a dual particle engineering approach10.1016/j.powtec.2018.10.054 ↗
35. Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals10.1016/j.jconrel.2019.01.023 ↗
36. Sustained release of plasmid DNA from PLLA/POSS nanofibers for angiogenic therapy10.1016/j.cej.2019.02.043 ↗
37. Pharmaceutical and biomaterial engineering via electrohydrodynamic atomization technologies10.1016/j.drudis.2016.09.021 ↗
38. 1D carbon nanofibers@TiO2 core-shell nanocomposites with enhanced photocatalytic activity toward CO2 reduction10.1016/j.jallcom.2018.02.265 ↗
39. Aligned conductive core-shell biomimetic scaffolds based on nanofiber yarns/hydrogel for enhanced 3D neurite outgrowth alignment and elongation10.1016/j.actbio.2019.06.035 ↗
40. Coaxial electrospinning formation of complex polymer fibers and their applications10.1002/cplu.201900281 ↗
41. Nanosized sustained-release drug depots fabricated using modified tri-axial electrospinning10.1016/j.actbio.2017.01.069 ↗
42. Electrospun lipid-coated medicated nanocomposites for an improved drug sustained-release profile10.1016/j.matdes.2018.11.036 ↗
43. Multifluid electrospinning for the generation of complex nanostructures10.1002/wnan.1601 ↗
44. Long-term antimicrobial effect of nisin released from electrospun triaxial fiber membranes10.1016/j.actbio.2017.02.029 ↗
45. Recent progress in coaxial electrospinning: new parameters, various structures, and wide applications10.1002/adma.201704765 ↗
46. Triaxial electrospun nanofiber membranes for controlled dual release of functional molecules10.1021/am402376c ↗
47. Highly flexible and tough concentric triaxial polystyrene fibers10.1021/am500837s ↗
48. Development of tripolymeric triaxial electrospun fibrous matrices for dual drug delivery applications10.1038/s41598-020-57412-0 ↗
49. Electrospun environment remediation nanofibers using unspinnable liquids as the sheath fluids: a review10.3390/polym12010103 ↗
50. Recent advances in electrospun nanofibers for some biomedical applications10.1016/j.ejps.2020.105224 ↗
51. Co-encapsulation of acyclovir and curcumin into microparticles improves the physicochemical characteristics and potentiates in vitro antiviral action: influence of the polymeric composition10.1016/j.ejps.2019.02.019 ↗
52. Development of a gastroretentive delivery system for acyclovir by 3D printing technology and its in vivo pharmacokinetic evaluation in Beagle dogs10.1371/journal.pone.0216875 ↗
53. Polymeric electrospun fibrous dressings for topical co-delivery of acyclovir and omega-3 fatty acids
54. The key role of straight fluid jet in predicting the drug dissolution from electrospun nanofibers10.1016/j.ijpharm.2019.118634 ↗
55. High energy density of polyimide composites containing one-dimensional BaTiO3@ZrO2 nanofibers for energy storage device10.1016/j.jallcom.2019.03.142 ↗
56. From Taylor cone to solid nanofiber in tri-axial electrospinning: size relationships10.1016/j.rinp.2019.102770 ↗
57. Cellulose acetate electrospun nanofibers for drug delivery systems: applications and recent advances10.1016/j.carbpol.2018.06.072 ↗
58. Replenishable drug depot to combat post-resection cancer recurrence10.1016/j.biomaterials.2018.05.005 ↗
59. Depot formulations to sustain periocular drug delivery to the posterior eye segment10.1016/j.drudis.2019.03.023 ↗
60. Evaluation of microscopic structure-function relationships of PEGylated small intestinal submucosa vascular grafts for arteriovenous connection10.1021/acsabm.9b00158 ↗
61. Locoregional cancer therapy using polymer-based drug depots10.1016/j.drudis.2016.02.014 ↗